Your session is about to expire
← Back to Search
DPCP for Skin Diseases
Study Summary
This trial will study how UV light affects the immune system and causes skin cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 18 and 35 years old.I have had an organ transplant, have an immune disorder, or am taking immunosuppressive medication.I plan to expose treated skin areas to the sun.I have a history of skin cancer.I understand what participating in the study involves and its risks.I am currently taking medication that increases my sensitivity to light.
- Group 1: Group 1 (Negative Control, 20 participants)
- Group 2: Group 2 (Positive Control, 20 participants)
- Group 3: Group 3 (UVB & Biopsy 30 participants)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies for individuals to take part in the clinical trial?
"According to clinicaltrials.gov, this trial is actively seeking participants who meet the criteria set out by researchers. The study was first posted on March 21st, 2022 and has subsequently been revised as of April 14th, 2022."
Is it possible for those aged 60 and above to partake in this medical experiment?
"Patients aged 18-70 are eligible to take part in this trial. Furthermore, there is an additional 14 studies available for those under the age of majority and 39 clinical trials geared towards individuals over retirement age."
How many participants are participating in this experiment?
"Affirmative. According to clinicaltrials.gov, this research trial which began on March 21st 2022 is still recruiting participants and has 70 spots left open at a single facility."
To whom is this experiment open for recruitment?
"This clinical trial is recruiting approximately 70 individuals aged 18-70 with skin disorders. Eligible participants must meet these criteria to be considered for the study."
What past experiments have been conducted with Diphenylcyclopropenone (DPCP)?
"There are currently two active clinical trials for Diphenylcyclopropenone (DPCP), one of which is in Phase 3. Most testing is occurring within Minneapolis, Minnesota; however, there are an additional two sites researching the efficacy of this drug."
Share this study with friends
Copy Link
Messenger